Carbamazepine and levetiracetam-loaded PLGA nanoparticles prepared by nanoprecipitation method: in vitro and in vivo studies

References

• Falco-Walter JJ, Scheffer IE, Fisher RS. The new definition and classification of seizures and epilepsy. Epilepsy Res. 2018;139:73–79.
   PubMed Web of Science ®Google Scholar
• WHO: epilepsy [Internet]; 2019; [cited 2019 Nov 7]. Available from: http://www.who.int/news-room/fact-sheets/detail/epilepsy#:∼:targetText=Epilepsy%20is%20a%20chronic%20noncommunicable,most%20common%20neurological%20diseases%20globally.&targetText=The%20risk%20of%20premature%20death,than%20for%20the%20general%20population
   Google Scholar
• Fisher RS, Van Emde Boas W, Blume W, et al. Epileptic seizures and epilepsy: definitions proposed by the International League Against Epilepsy (ILAE) and the International Bureau for Epilepsy (IBE). Epilepsia. 2005;46(4):470–472.
   PubMed Web of Science ®Google Scholar
• Biraben A, De Clerck L, Nica A. Epilepsy treatment in the elderly. Geriatr Psychol Neuropsychiatr Vieil. 2019;17(S1):31–38.
   PubMedGoogle Scholar
• Liu G, Slater N, Perkins A. Epilepsy: treatment options. Am Fam Physician. 2017;96(2):87–96.
   PubMed Web of Science ®Google Scholar
• Magiorkinis E, Diamantis A, Sidiropoulou K, et al. Highlights in the history of epilepsy: the last 200 years. Epilepsy Res Treat. 2014;2014:582039.
   PubMedGoogle Scholar
• Dvir N, Javaid MS, Jones NC, et al. The effects of cell therapy on seizures in animal models of epilepsy: protocol for systematic review and meta-analysis of preclinical studies. Syst Rev. 2019;8(1):255.
   PubMed Web of Science ®Google Scholar
• Willems LM, Bauer S, Rosenow F, et al. Recent advances in the pharmacotherapy of epilepsy: brivaracetam and perampanel as broad-spectrum antiseizure drugs for the treatment of epilepsies and status epilepticus. Expert Opin Pharmacother. 2019;20(14):1755–1765.
   PubMed Web of Science ®Google Scholar
• Nadkarni S, LaJoie J, Devinsky O. Current treatments of epilepsy. Neurology. 2005;64(12 Suppl. 3):S2–S11.
   PubMed Web of Science ®Google Scholar
• Goldenberg MM. Overview of drugs used for epilepsy and seizures: etiology, diagnosis, and treatment. P T. 2010;35(7):392–415.
   PubMedGoogle Scholar
• Tolou-Ghamari Z, Zare M, Habibabadi JM, et al. A quick review of carbamazepine pharmacokinetics in epilepsy from 1953 to 2012. J Res Med Sci. 2013;18(Suppl. 1):S81–S85.
   PubMed Web of Science ®Google Scholar
• Zybina A, Anshakova A, Malinovskaya J, et al. Nanoparticle-based delivery of carbamazepine: a promising approach for the treatment of refractory epilepsy. Int J Pharm. 2018;547(1–2):10–23.
   PubMedGoogle Scholar
• Scioli Montoto S, Sbaraglini ML, Talevi A, et al. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: physicochemical characterization and in vitro/in vivo evaluation. Colloids Surf B Biointerfaces. 2018;167:73–81.
   PubMed Web of Science ®Google Scholar
• Ana R, Mendes M, Sousa J, et al. Rethinking carbamazepine oral delivery using polymer–lipid hybrid nanoparticles. Int J Pharm. 2019;554:352–365.
   PubMed Web of Science ®Google Scholar
• Igartúa DE, Martinez CS, Temprana CF, et al. PAMAM dendrimers as a carbamazepine delivery system for neurodegenerative diseases: a biophysical and nanotoxicological characterization. Int J Pharm. 2018;544(1):191–202.
   PubMedGoogle Scholar
• Erukula SV, Srivari Y, Chatterjee P. Factors influencing the fabrication of albumin-bound drug nanoparticles (ABDns). Part II. Albumin-bound carbamazepine nanoparticles (ABCns). J Microencapsul. 2016;33(6):524–534.
   PubMed Web of Science ®Google Scholar
• Otoul C, De Smedt H, Stockis A. Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy. Epilepsia. 2007;48(11):2111–2115.
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA. Levetiracetam: a review of its use in epilepsy. Drugs. 2011;71(4):489–514.
   PubMed Web of Science ®Google Scholar
• Derman S, Kızılbey K, Akdeste ZM. Polymeric nanoparticles. J Eng Nat Sci. 2013;31:107–120.
   Google Scholar
• DeLuca PP, Mehta RC, Hausberger AG, et al. Biodegradable polyesters for drug and polypeptide delivery. In: El-Nokaly MA, Piatt DM, Charpentier BA, editors. Polymeric delivery systems: properties and applications. California: American Chemical Society; 1993. p. 53–79.
   Google Scholar
• Zeng X, Tao W, Mei L, et al. Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel deliver to cervical cancer. Biomaterials. 2013;34(25):6058–6067.
   PubMed Web of Science ®Google Scholar
• Peng Y, Nie J, Cheng W, et al. A multifunctional nanoplatform for cancer chemo-photothermal synergistic therapy and overcoming multidrug resistance. Biomater Sci. 2018;6(5):1084–1098.
   PubMed Web of Science ®Google Scholar
• Musumeci T, Serapide MF, Pellitteri R, et al. Oxcarbazepine free or loaded PLGA nanoparticles as effective intranasal approach to control epileptic seizures in rodents. Eur J Pharm Biopharm. 2018;133:309–320.
   PubMed Web of Science ®Google Scholar
• Cano A, Ettcheto M, Espina M, et al. Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: a new anti-seizure strategy for temporal lobe epilepsy. Nanomedicine. 2018;14(4):1073–1085.
   PubMed Web of Science ®Google Scholar
• Florek-Luszczki M, Wlaz A, Luszczki JJ. Interactions of levetiracetam with carbamazepine, phenytoin, topiramate and vigabatrin in the mouse 6 Hz psychomotor seizure model – a type II isobolographic analysis. Eur J Pharmacol. 2014;723:410–418.
   PubMed Web of Science ®Google Scholar
• Kaminski RM, Matagne A, Patsalos PN, et al. Benefit of combination therapy in epilepsy: a review of the preclinical evidence with levetiracetam. Epilepsia. 2009;50(3):387–397.
   PubMed Web of Science ®Google Scholar
• Kandilli B, Uğur AB, Çetin M, et al. A simple HPLC-UV method for simultaneous determination of levetiracetam and carbamazepine. Hacettepe Univ J Fac Pharm. 2018;38:58–64.
   Google Scholar
• Chen W, Hu S. Suitable carriers for encapsulation and distribution of endostar: comparison of endostar-loaded particulate carriers. Int J Nanomedicine. 2011;6:1535–1541.
   PubMed Web of Science ®Google Scholar
• Ergul Erkec O, Arihan O. Pentylenetetrazol kindling epilepsy model. J Turk Epilepsi Soc. 2015;21:6–12.
   Web of Science ®Google Scholar
• Fischer W, Kittner H. Influence of ethanol on the pentylenetetrazol-induced kindling in rats. J Neural Transm (Vienna). 1998;105(10–12):1129–1142.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Gupta BK, Jaggi M, et al. Fabrication of curcumin encapsulated PLGA nanoparticles for improved therapeutic effects in metastatic cancer cells. J Colloid Interface Sci. 2010;351(1):19–29.
   PubMed Web of Science ®Google Scholar
• Grzesiak AL, Lang M, Kim K, et al. Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of form I. J Pharm Sci. 2003;92(11):2260–2271.
   PubMed Web of Science ®Google Scholar
• Kumar R, Siril PF. Ultrafine carbamazepine nanoparticles with enhanced water solubility and rate of dissolution. RSC Adv. 2014;4(89):48101–48108.
   Web of Science ®Google Scholar
• Rustichelli C, Gamberini G, Ferioli V, et al. Solid-state study of polymorphic drugs: carbamazepine. J Pharm Biomed Anal. 2000;23(1):41–54.
   PubMed Web of Science ®Google Scholar
• Dangi AA, Ganure Ashok L, Divya J. Formulation and evaluation of colon targeted drug delivery system of levetiracetam using pectin as polymeric carrier. J Appl Pharm Sci. 2013;3:78–87.
   Google Scholar
• Paliwal H, Goyal S, Rathore KS, et al. Formulation and evaluation of levetiracetam extended release tablets. Int J Pharm Sci Rev Res. 2016;41:260–266.
   Google Scholar
• Mainardes RM, Gremiao MPD, Evangelista RC. Thermoanalytical study of praziquantel-loaded PLGA nanoparticles. Rev Bras Cienc Farm. 2006;42(4):523–530.
   Google Scholar
• Raghavendra Rao NG, Patel T, Gandhi S. Development and evaluation of carbamazepine fast dissolving tablets prepared with a complex by direct compression technique. Asian J Pharm. 2009;3(2):97–103.
   Google Scholar
• Panchal JG, Patel RV, Menon SK. Preparation and physicochemical characterization of carbamazepine (CBMZ): para-sulfonated calix[n]arene inclusion complexes. J Incl Phenom Macrocycl Chem. 2010;67(1–2):201–208.
   Web of Science ®Google Scholar
• Akbari Z, Amanlou M, Karimi-Sabet J, et al. Characterization of carbamazepine-loaded solid lipid nanoparticles prepared by rapid expansion of supercritical solution. Trop J Pharm Res. 2015;13(12):1955–1961.
   Web of Science ®Google Scholar
• Samifar S, Akki R, Ramya GM, et al. Development and characterization of carbamazepine loaded nonionic surfactant vesicles. Acta Chim Pharm Indica. 2015;5:29–40.
   Google Scholar
• Sivaneswari S, Karthikeyan E, Chandana PJ. Novel expandable gastro retentive system by unfolding mechanism of levetiracetam using simple lattice design – formulation optimization and in vitro evaluation. Bull Fac Pharm Cairo Univ. 2017;55(1):63–72.
   Google Scholar
• Mannam AK. Formulation and evaluation of levetiracetam niosomes for improved anti-convulsant activity [master’s thesis]. Coımbatore: The Tamil Nadu Dr. M.G.R Medical University; 2014.
   Google Scholar
• Gao Q, Liang Q, Yu F, et al. Synthesis and characterization of novel amphiphilic copolymer stearic acid-coupled F127 nanoparticles for nano-technology based drug delivery system. Colloids Surf B Biointerfaces. 2011;88(2):741–748.
   PubMed Web of Science ®Google Scholar
• Mansouri S, Ataei ML, Hosseini M, et al. Tamoxifen mimics the effects of endogenous ovarian hormones on repeated seizures induced by pentylenetetrazole in rats. Exp Neurobiol. 2013;22(2):116–123.
   PubMedGoogle Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3):1377–1397.
   PubMed Web of Science ®Google Scholar
• Tummala S, Kumar MNS, Prakash A. Formulation and in vitro characterization of carbamazepine polymeric nanoparticles with enhanced solubility and sustained release for the treatment of epilepsy. J Chem Pharm Res. 2015;7:70–79.
   Google Scholar
• Luszczki JJ, Andres MM, Czuczwar P, et al. Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis. Epilepsia. 2006;47(1):10–20.
   PubMed Web of Science ®Google Scholar
• Kanemura H, Sano F, Ohyama T, et al. Efficacy of levetiracetam as first add-on therapy to carbamazepine and valproate sodium for children with epilepsy. J Pediatr Epilepsy. 2015;3(2):77–83.
   Google Scholar
• Santander-Ortega MJ, Jódar-Reyes AB, Csaba N, et al. Colloidal stability of Pluronic F68-coated PLGA nanoparticles: a variety of stabilisation mechanisms. J Colloid Interface Sci. 2006;302(2):522–529.
   PubMed Web of Science ®Google Scholar
• Mura S, Hillaireau H, Nicolas J, et al. Influence of surface charge on the potential toxicity of PLGA nanoparticles towards Calu-3 cells. Int J Nanomedicine. 2011;6:2591–2605.
   PubMed Web of Science ®Google Scholar
• Shah U, Joshi G, Sawant K. Improvement in antihypertensive and antianginal effects of felodipine by enhanced absorption from PLGA nanoparticles optimized by factorial design. Mater Sci Eng C. 2014;35:153–163.
   PubMed Web of Science ®Google Scholar
• Govender T, Stolnik S, Garnett MC, et al. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release. 1999;57(2):171–185.
   PubMed Web of Science ®Google Scholar
• Lucero-Acuña A, Gutiérrez-Valenzuela CA, Esquivel R, et al. Mathematical modeling and parametrical analysis of the temperature dependency of control drug release from biodegradable nanoparticles. RSC Adv. 2019;9(16):8728–8739.
   PubMed Web of Science ®Google Scholar
• Reddy KV, Kumar MA, Kumar GV. Isradipine enhances the anticonvulsant activity of carbamazepine against MES and PTZ induced convulsions in rats. Int J Pharm Sci Res. 2015;6:247–250.
   Web of Science ®Google Scholar
• Akula KK, Dhir A, Kulkarni SK. Effect of various antiepileptic drugs in a pentylenetetrazol-induced seizure model in mice. Methods Find Exp Clin Pharmacol. 2009;31(7):423–432.
   PubMedGoogle Scholar
• Sisodiya SM, Sander J, Patsalos PN. Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction. Epilepsy Res. 2002;48(3):217–219.
   PubMed Web of Science ®Google Scholar
• Nair R, Kumar AC, Priya VK, et al. Formulation and evaluation of chitosan solid lipid nanoparticles of carbamazepine. Lipids Health Dis. 2012;11:72–78.
   PubMed Web of Science ®Google Scholar